ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.88
+0.09 (0.95%)
Jun 25, 2026, 2:55 PM EDT - Market open
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$410,059
Profits / Employee
-$7,471
Market Cap
89.41M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Biomea Fusion | 41 |
| Aardvark Therapeutics | 40 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| iBio, Inc. | 20 |
ICCC News
- 13 days ago - ImmuCell Slides: Investor presentation - Filings
- 14 days ago - ImmuCell Transcript: AGM 2026 - Transcripts
- 5 weeks ago - ImmuCell Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - ImmuCell Quarterly report: Q1 2026 - Filings
- 5 weeks ago - ImmuCell Earnings release: Q1 2026 - Filings
- 5 weeks ago - ImmuCell Slides: Q1 2026 - Filings
- 5 weeks ago - ImmuCell Slides: Investor presentation - Filings
- 5 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 - GlobeNewsWire